Tumor hypoxic microenvironment has been shown to provoke the activation of angiogenesis factors such as VEGF/EGF/TGF-β, CSCs and EMT, and drug resistance in a variety of tumor types [18,50]. This evidence concerns the gene VEGFA and neoplasm.